Astellas Pharma | 4503 - Operating Expenses


Astellas Pharma reported JPY489.36B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Astellas Pharma JPY 489.36B 52.69B Mar/2026
Chugai Pharma JPY 180.73B 17.74B Jun/2026
Daiichi Sankyo JPY 489.64B 21.08B Jun/2026
Eisai JPY 209.6B 6.14B Jun/2026
Kyowa Hakko Kirin JPY 122.9B 13.95B Jun/2026
M3 JPY 76.32B 8.83B Mar/2026
Otsuka Holdings JPY 561.64B 49.51B Jun/2026
Shionogi JPY 96.4B 24.61B Jun/2026
Sumitomo Dainippon JPY 111.74B 2.64B Jun/2026
Takeda JPY 1.02T 89.68B Jun/2026
Terumo JPY 268.87B 16.12B Mar/2026